+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
T-cell Malignancies - Pipeline Insight, 2024 - Product Thumbnail Image

T-cell Malignancies - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Metastatic Cutaneous Squamous Cell Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Cutaneous Squamous Cell Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HER2-mutant Non-Small Cell Lung Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2-mutant Non-Small Cell Lung Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Advanced Merkel cell carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Merkel cell carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
VS-6766 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

VS-6766 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
RUBRACA Market Size, Forecast, and Drug Insight - 2032 - Product Thumbnail Image

RUBRACA Market Size, Forecast, and Drug Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
OSE-2101 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

OSE-2101 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
OPDIVO Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

OPDIVO Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
From
KEYTRUDA Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

KEYTRUDA Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
DKN-01 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

DKN-01 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 120 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Oligodendroglioma - Pipeline Insight, 2024 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Familial Adenomatous Polyposis Coli - Pipeline Insight, 2024 - Product Thumbnail Image

Familial Adenomatous Polyposis Coli - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Metastatic Liver Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Liver Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more